Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Jundishapur Journal of Chronic Disease Care
  4. Articles

  5. The Relationship Between Blood Group and Colon Cancer in Shiraz Namazi Hospital During 2002 - 2011
  6. Scopus by Title (Ref)

Jundishapur Journal of Chronic Disease Care

The Official Journal of Ahvaz Jundishapur University of Medical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. ABO and Rhesus blood group markers as predictors in colorectal cancer: A prospective observational study

- Rashid G. , et al.

2. Comparing the Effects of Psychodynamic Group Psychotherapy and Mindfulness-Based Stress Reduction on Body Image and Emotional Processing in Patients with Colorectal Cancer

- Andalib L. , et al.

3. A Study of Association of ABO and Rh Blood Group with Colorectal Cancer in Khuzestan Province, Iran

- Jodat H. , et al.

4. Relationship Between ABO Blood Group and the Risk of Colorectal Cancer: A Retrospective Multicenter Study

- Al-Sawat A. , et al.

HomeInstructionsAPC

Archives

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.